News CDM scoops "Best of Show" at PM Society Awards A diabetes awareness campaign from CDM London proved to be the “Best of Show” at this year’s PM Society Awards, recognising the crème de la crème in pharma marketing.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.